South Korea · Delayed Price · Currency is KRW Dong-A Socio Holdings Company Description
Dong-A Socio Holdings Co., Ltd., together with its subsidiaries, engages in the pharmaceutical business in South Korea.
It operates through Holding Company; Over-the-Counter Drugs and Quai-Drugs; Biosimilars and Consignment Medicines; Logistics; Packaging Solutions; and Others segments.
The company develops DA-8010 in Phase 3 clinical trial to treat overactive bladder; DMB-3115, a biosimilar of Stelara in Phase 3 clinical trial; DA-1241 in Phase 2 clinical trial for the treatment of non-alcoholic steatohepatitis; DA-1726 in Phase 1 clinical trial to treat obesity; and STP0404 for the treatment of AIDS.
It also provides medical devices and equipment; healthcare solutions to customers in Bacchus, over-the-counter, consumer healthcare, and cosmetics; health functional food; contract development and manufacturing organization for biosimilar and pharmaceutical products, and oligonucleotide therapeutics; functional sports drinks under the POCARI SWEAT brand; logistics and fulfillment services; glass bottles, PET bottles, aluminum and plastic caps, and paper packaging boxes; mineral and carbonated water, and mixed drinks; and IT and construction services.
In addition, the company is involved in engineering; cargo, courier, and automobile transport arrangement; transportation warehousing and leasing; real estate development; agricultural product distribution; management consulting; business management; and architectural, electric work, fire protection, and housing contracting services.
Dong-A Socio Holdings Co., Ltd. was founded in 1932 and is headquartered in Seoul, South Korea.
| Country | South Korea |
| Founded | 1932 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 5,530 |
| CEO | Min-Young Kim |
Contact Details
Address: 64, Cheonho-daero Seoul, 02587 South Korea | |
| Phone | 82 2 920 8114 |
| Website | donga.co.kr |
Stock Details
| Ticker Symbol | 000640 |
| Exchange | Korea Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7000640003 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Min-Young Kim | Chief Executive Officer and Executive Director |
| Seung Hyun Ko | Executive Director, Chief Financial Officer and Head of Management Support Office |
| Hyun-Min Lee | Executive Director and Head of Business Planning Office |